Literature DB >> 33477771

Predominance of Candida Glabrata among Non-albicans Candida Species in a 16-Year Study of Candidemia at a Tertiary Care Center in Lebanon.

Aline El Zakhem1, Rachid Istambouli1, Maria Alkozah1, Amal Gharamti1, Mohamad Ali Tfaily1, Jean-Francois Jabbour1, George F Araj2, Hani Tamim1, Souha S Kanj1.   

Abstract

BACKGROUND: Candidemia is associated with a high mortality rate, and its incidence is increasing worldwide with a rise in non-albicans candidemia (NAC). Epidemiologic data from Arab countries are scarce and there are no data from Lebanon;
Methods: This is a single-center retrospective chart review of patients with candidemia in a tertiary care center in Lebanon from 2004 to 2019. We extracted data on patient characteristics, isolated Candida species antifungal susceptibility, management and outcomes;
Results: We included 170 cases of candidemia. NAC was more common than albicans candidemia (64.7% vs. 35.3%). C. glabrata was the most common non-albicans species (37 isolates) followed by C. tropicalis (14). Recent use of antifungals was a risk factor for NAC (OR = 2.8, p = 0.01), while the presence of a central venous catheter was protective (OR = 0.41, p = 0.02). Fluconazole resistance was 12.5% in C. albicans and 21.5% in non-albicans spp. Mortality at 30 days was 55.5%, with no difference between NAC and albicans candidemia. It was higher in older and critically ill patients but lower in patients whose central venous catheter was removed after detecting fungemia; Conclusions: Candidemia is associated with high mortality in Lebanon, with a predominance of NAC and high prevalence of C. glabrata.

Entities:  

Keywords:  Arab world; Candida glabrata; Lebanon; antifungal susceptibility; candidemia; invasive candidiasis; non-albicans Candida

Year:  2021        PMID: 33477771      PMCID: PMC7832319          DOI: 10.3390/pathogens10010082

Source DB:  PubMed          Journal:  Pathogens        ISSN: 2076-0817


  34 in total

1.  Risk factors, clinical presentation and prognosis of mixed candidaemia: a population-based surveillance in Spain.

Authors:  Antonio Ramos; Yolanda Romero; Isabel Sánchez-Romero; Jesús Fortún; José Ramón Paño; Javier Pemán; Mercè Gurguí; Jesús Rodríguez-Baño; Belén Padilla
Journal:  Mycoses       Date:  2016-07-21       Impact factor: 4.377

2.  Antifungal susceptibility of bloodstream Candida isolates in Sfax hospital: Tunisia.

Authors:  A Sellami; H Sellami; S Néji; F Makni; S Abbes; F Cheikhrouhou; H Chelly; M Bouaziz; B Hammami; M Ben Jemaa; S Khaled; A Ayadi
Journal:  Mycopathologia       Date:  2010-12-19       Impact factor: 2.574

3.  Distribution and epidemiology of Candida species causing fungemia at a Saudi Arabian hospital, 1996-2004.

Authors:  Jaffar A Al-Tawfiq
Journal:  Int J Infect Dis       Date:  2006-07-21       Impact factor: 3.623

4.  Predictors and outcomes of Candida bloodstream infection: eight-year surveillance, western Saudi Arabia.

Authors:  Abdul Hakeem O Al Thaqafi; Fayssal M Farahat; Maher I Al Harbi; Abdul Fattah W Al Amri; John R Perfect
Journal:  Int J Infect Dis       Date:  2014-01-25       Impact factor: 3.623

5.  Factors associated with candidemia caused by non-albicans Candida species versus Candida albicans in the intensive care unit.

Authors:  Jennifer K Chow; Yoav Golan; Robin Ruthazer; Adolf W Karchmer; Yehuda Carmeli; Deborah Lichtenberg; Varun Chawla; Janet Young; Susan Hadley
Journal:  Clin Infect Dis       Date:  2008-04-15       Impact factor: 9.079

6.  Clinical and microbiological factors associated with mortality in candidemia in adult patients 2007-2016.

Authors:  Mari Ala-Houhala; Miia Valkonen; Elina Kolho; Nathalie Friberg; Veli-Jukka Anttila
Journal:  Infect Dis (Lond)       Date:  2019-09-11

7.  Antifungal susceptibility of Candida isolates at the American University of Beirut Medical Center.

Authors:  G F Araj; N K Daher; Z A Tabbarah
Journal:  Int J Antimicrob Agents       Date:  1998-11       Impact factor: 5.283

8.  Candida spp. with acquired echinocandin resistance, France, 2004-2010.

Authors:  Eric Dannaoui; Marie Desnos-Ollivier; Dea Garcia-Hermoso; Fredéric Grenouillet; Sophie Cassaing; Marie-Thérèse Baixench; Stéphane Bretagne; Françoise Dromer; Olivier Lortholary
Journal:  Emerg Infect Dis       Date:  2012-01       Impact factor: 6.883

9.  Worrisome trends in incidence and mortality of candidemia in intensive care units (Paris area, 2002-2010).

Authors:  Olivier Lortholary; Charlotte Renaudat; Karine Sitbon; Yoann Madec; Lise Denoeud-Ndam; Michel Wolff; Arnaud Fontanet; Stéphane Bretagne; Françoise Dromer
Journal:  Intensive Care Med       Date:  2014-08-06       Impact factor: 17.440

10.  Characteristics and risk factors for 28-day mortality of hospital acquired fungemias in ICUs: data from the EUROBACT study.

Authors:  José-Artur Paiva; José Manuel Pereira; Alexis Tabah; Adam Mikstacki; Frederico Bruzzi de Carvalho; Despoina Koulenti; Stéphane Ruckly; Nahit Çakar; Benoit Misset; George Dimopoulos; Massimo Antonelli; Jordi Rello; Xiaochun Ma; Barbara Tamowicz; Jean-François Timsit
Journal:  Crit Care       Date:  2016-03-09       Impact factor: 9.097

View more
  2 in total

1.  The Catestatin-Derived Peptides Are New Actors to Fight the Development of Oral Candidosis.

Authors:  Davide Mancino; Naji Kharouf; Francesco Scavello; Sophie Hellé; Fouad Salloum-Yared; Angela Mutschler; Eric Mathieu; Philippe Lavalle; Marie-Hélène Metz-Boutigue; Youssef Haïkel
Journal:  Int J Mol Sci       Date:  2022-02-13       Impact factor: 5.923

2.  The Utility of EQUAL Candida Score in Predicting Mortality in Patients with Candidemia.

Authors:  Aline El Zakhem; Rozana El Eid; Rachid Istambouli; Hani Tamim; Souha S Kanj
Journal:  J Fungi (Basel)       Date:  2022-02-27
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.